Research Article
[Retracted] Camrelizumab and Apatinib Combined with Radiotherapy Is Effective in Advanced Oligometastatic Non-Small-Cell Lung Cancer
Table 2
Comparison of disease control rates between the two groups (cases, %).
| Group | CR | PR | DC | DP | Disease control rate |
| Observation group (n = 53) | 25 (47.17) | 17 (32.08) | 7 (13.21) | 4 (7.55) | 92.45 | Control group (n = 33) | 10 (30.30) | 12 (36.36) | 4 (12.12) | 7 (21.21) | 78.79 | χ 2 | — | 18.736 | | | | | — | <0.001 | | | |
|
|